UBS Group
SKBI

UBS Group’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

UBS Group’s Portfolio SKBI Stock Details SKBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,304
Closed -$3K – 8856
2015
Q3 		$3K Sell
3,304
-78
-2% -$125 ﹤0.01% 8023
2015
Q2 		$9K Buy
+3,382
New +$11.6K ﹤0.01% 7584

Other funds holding SKBI

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

UBS Group's SKBI Position: Q4 2015 in Review

UBS Group sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q4 2015, closing a stake of 3,304 shares — an estimated $3K sold.

UBS Group first reported a position in SKBI in Q2 2015 and held it in 2 quarters. The position peaked at $9K in Q2 2015. 1 fund tracked by Wall St. Rank holds SKBI as of Q4 2015.

  • UBS Group reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q4 2015 after selling out during the quarter.
  • UBS Group sold 3,304 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q4 2015, an estimated $3K.
  • UBS Group first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q2 2015 and held it in 2 quarters.
  • UBS Group's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $9K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q4 2015.

Based on UBS Group's 13F filing for Q4 2015, filed 16 Feb 2016.